About this trial
This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver
Disqualifiers
Failure to obtain consent/assent (as indicated)
Trial population
Children (\<21 years of age) receiving drugs per standard of care as prescribed by treating caregiver
Trial design
Cohort
Prospective
Treatments tested in this trial
Standard of care drug
DrugThis study is collecting PK data on children prescribed the following drugs of interest per standard of care: dexmedetomidine, bosentan, furosemide, chlorothiazide, ethacrynic acid, bumetanide, hydromorphone, tacrolimus, ampicillin, gentamicin, caffeine, fentanyl, midazolam, foscarnet, hydroxychloroquine, and moxifloxacin.
Treatment groups
Trial outcomes
Primary outcomes
Area under the curve (AUC)
Secondary outcomes
Maximum concentration (Cmax)
Time to achieve maximum concentration (Tmax)
Absorption rate constant (ka)
Elimination rate constant (kel)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.